A detailed history of Royal Bank Of Canada transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 46,501 shares of VNDA stock, worth $202,744. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,501
Previous 58,062 19.91%
Holding current value
$202,744
Previous $328,000 33.54%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.61 - $6.34 $53,296 - $73,296
-11,561 Reduced 19.91%
46,501 $218,000
Q2 2024

Aug 14, 2024

SELL
$3.91 - $6.5 $43,471 - $72,267
-11,118 Reduced 16.07%
58,062 $328,000
Q1 2024

Nov 05, 2024

BUY
$3.47 - $4.61 $38,579 - $51,253
11,118 Added 19.15%
69,180 $284,000
Q1 2024

May 15, 2024

BUY
$3.47 - $4.61 $105,470 - $140,120
30,395 Added 78.37%
69,180 $284,000
Q4 2023

Feb 14, 2024

SELL
$3.38 - $4.58 $118,381 - $160,409
-35,024 Reduced 47.45%
38,785 $163,000
Q3 2023

Nov 14, 2023

SELL
$4.28 - $6.57 $6,848 - $10,512
-1,600 Reduced 2.12%
73,809 $318,000
Q2 2023

Aug 14, 2023

BUY
$5.9 - $6.95 $39,889 - $46,988
6,761 Added 9.85%
75,409 $496,000
Q1 2023

May 15, 2023

BUY
$6.18 - $7.99 $290,070 - $375,026
46,937 Added 216.19%
68,648 $466,000
Q4 2022

Feb 14, 2023

BUY
$6.87 - $10.96 $3,270 - $5,216
476 Added 2.24%
21,711 $160,000
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $2,643 - $3,292
280 Added 1.34%
21,235 $210,000
Q2 2022

Aug 15, 2022

BUY
$9.31 - $11.84 $456 - $580
49 Added 0.23%
20,955 $229,000
Q1 2022

May 16, 2022

SELL
$10.84 - $16.55 $7,761 - $11,849
-716 Reduced 3.31%
20,906 $236,000
Q4 2021

Feb 14, 2022

SELL
$15.69 - $21.14 $910 - $1,226
-58 Reduced 0.27%
21,622 $340,000
Q3 2021

Nov 15, 2021

BUY
$15.35 - $21.27 $11,251 - $15,590
733 Added 3.5%
21,680 $372,000
Q2 2021

Aug 16, 2021

BUY
$15.71 - $21.51 $329,077 - $450,569
20,947 New
20,947 $451,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $247M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.